Loading…
Loading…
The latest trading day saw Nice (NICE) settling at $101.34, representing a +1.19% change from its previous close.
Nice (NICE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Enables natural orifice extraction of tissue without surgical incision SINGAPORE, July 20, 2026 /PRNewswire/ -- NICE Surgical Solutions Pte Ltd ("NICE Surgical"), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments, has been granted U.S. Patent No. 12,661,097 B2, for its extracting device used in conjunction with its novel purse-string stapler, generally eliminating the need for surgical incisions in colorectal surgery.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
NICE provides highly profitable AI-driven customer engagement solutions and financial crime compliance software. Twilio offers a massive programmable communications platform that powers messaging and data for over 402,000 active accounts.
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (NASDAQ: NICE) today announced that Banco do Brasil, one of Latin America's largest financial institutions, is leveraging NiCE Copilot to accelerate operational excellence and elevate customer service across its organization. Embedded natively within the unified NiCE CXone AI platform used by relationship managers and banking assistants, NiCE Copilot brings agentic AI-powered guidance and automation into everyday banking workflows. This seamless experience e.
On July 13, 2026, NICE Ltd (NICE) shares rose 3.8% to a current price of $103.48. This move comes amid a 52-week range that has seen a high of $175.00 and a low
In the latest trading session, Nice (NICE) closed at $97.86, marking a +1.1% move from the previous day.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for NICE and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.